Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Adimmune
Deal Size : Undisclosed
Deal Type : Agreement
Details : Under the terms of the Master Service Agreement, JHL Biotech will support Adimmune Corporation to manufacture and supply the Antigen for their leading Covid-19 vaccine candidate.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
November 09, 2020
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Adimmune
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : National Institutes of Health
Deal Size : Undisclosed
Deal Type : Collaboration
Taiwan firm teams up with US to develop Covid-19 vaccine
Details : Medigen signed an agreement with the NIH allowing it to obtain the candidate vaccine virus for potential use in humans to jump-start candidate vaccine development for Covid-19 in Taiwan.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
February 17, 2020
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : National Institutes of Health
Deal Size : Undisclosed
Deal Type : Collaboration